#28 Catching black swans – François Montastruc
Drug Safety Matters
English - February 29, 2024 08:00 - 27 minutes - 18.8 MBMedicine Health & Fitness Science Life Sciences drug safety healthcare medicine medicines safety patient safety pharmacovigilance side effects Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unpredictable.
Tune in to find out:
What Nassim Nicholas Taleb’s ‘black swan’ theory has to do with pharmacovigilanceWhat makes an adverse drug reaction a black, white, or grey swan Why flexibility and communication are key to patient safetyWant to know more?
Here are the research articles cited in the episode:
If you enjoyed this podcast, check out these related episodes from the Drug Safety Matters archive:
Reforming pharmacovigilance educationLessons in pandemic pharmacovigilanceIntuition in pharmacovigilanceJoin the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.